MoneyWorks4Me

Ajanta Pharma informs about certificate

07 Jul 2026 Evaluate
Ajanta Pharma has informed that it enclosed a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2026 received from MUFG Intime India (formerly known as Link Intime India), Registrar and Share Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1857.05
Dr. Reddys Labs. 1170.90
Cipla 1374.85
Lupin 2087.75
Zydus Lifesciences 1133.50
View more..